Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs PLETHICO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA PLETHICO PHARMA ALEMBIC PHARMA/
PLETHICO PHARMA
 
P/E (TTM) x 32.2 -0.1 - View Chart
P/BV x 4.4 0.0 26,360.6% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 ALEMBIC PHARMA   PLETHICO PHARMA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-23
PLETHICO PHARMA
Mar-14
ALEMBIC PHARMA/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs792254 311.9%   
Low Rs46331 1,482.6%   
Sales per share (Unadj.) Rs287.6604.6 47.6%  
Earnings per share (Unadj.) Rs17.432.5 53.6%  
Cash flow per share (Unadj.) Rs31.451.3 61.2%  
Dividends per share (Unadj.) Rs8.000-  
Avg Dividend yield %1.30-  
Book value per share (Unadj.) Rs222.3473.7 46.9%  
Shares outstanding (eoy) m196.5634.07 576.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.20.2 925.5%   
Avg P/E ratio x36.14.4 822.0%  
P/CF ratio (eoy) x20.02.8 719.5%  
Price / Book Value ratio x2.80.3 937.9%  
Dividend payout %46.00-   
Avg Mkt Cap Rs m123,4024,859 2,539.8%   
No. of employees `000NANA-   
Total wages/salary Rs m11,6911,547 755.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m56,52620,598 274.4%  
Other income Rs m30419 7.2%   
Total revenues Rs m56,55721,017 269.1%   
Gross profit Rs m6,7722,938 230.5%  
Depreciation Rs m2,754642 428.8%   
Interest Rs m5021,747 28.7%   
Profit before tax Rs m3,546968 366.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m126-138 -91.1%   
Profit after tax Rs m3,4201,107 309.0%  
Gross profit margin %12.014.3 84.0%  
Effective tax rate %3.6-14.3 -24.9%   
Net profit margin %6.15.4 112.6%  
BALANCE SHEET DATA
Current assets Rs m29,13918,877 154.4%   
Current liabilities Rs m16,40811,896 137.9%   
Net working cap to sales %22.533.9 66.5%  
Current ratio x1.81.6 111.9%  
Inventory Days Days1078 12.4%  
Debtors Days Days7198 3.4%  
Net fixed assets Rs m31,49814,269 220.7%   
Share capital Rs m393341 115.4%   
"Free" reserves Rs m43,31215,798 274.2%   
Net worth Rs m43,70516,139 270.8%   
Long term debt Rs m04,706 0.0%   
Total assets Rs m60,63733,146 182.9%  
Interest coverage x8.11.6 519.0%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.90.6 150.0%   
Return on assets %6.58.6 75.1%  
Return on equity %7.86.9 114.1%  
Return on capital %9.313.0 71.1%  
Exports to sales %46.421.4 216.9%   
Imports to sales %12.115.2 79.5%   
Exports (fob) Rs m26,2104,402 595.4%   
Imports (cif) Rs m6,8463,136 218.3%   
Fx inflow Rs m26,2104,402 595.4%   
Fx outflow Rs m6,8463,184 215.0%   
Net fx Rs m19,3641,219 1,589.2%   
CASH FLOW
From Operations Rs m7,2402,437 297.0%  
From Investments Rs m-4,476-6,265 71.4%  
From Financial Activity Rs m-2,6202,490 -105.2%  
Net Cashflow Rs m14424 587.8%  

Share Holding

Indian Promoters % 69.1 57.8 119.7%  
Foreign collaborators % 0.5 0.0 -  
Indian inst/Mut Fund % 19.0 19.4 98.0%  
FIIs % 4.5 2.7 167.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 42.3 71.9%  
Shareholders   85,212 16,430 518.6%  
Pledged promoter(s) holding % 0.0 85.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALEMBIC PHARMA vs PLETHICO PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC PHARMA vs PLETHICO PHARMA Share Price Performance

Period ALEMBIC PHARMA PLETHICO PHARMA S&P BSE HEALTHCARE
1-Day -0.15% -4.91% 1.18%
1-Month -4.30% -1.24% -0.75%
1-Year 105.43% -70.21% 61.82%
3-Year CAGR 0.89% -66.86% 18.16%
5-Year CAGR 13.56% -51.20% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC PHARMA share price and the PLETHICO PHARMA share price.

Moving on to shareholding structures...

The promoters of ALEMBIC PHARMA hold a 69.6% stake in the company. In case of PLETHICO PHARMA the stake stands at 57.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC PHARMA and the shareholding pattern of PLETHICO PHARMA.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC PHARMA paid a dividend of Rs 8.0 per share. This amounted to a Dividend Payout ratio of 46.0%.

PLETHICO PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of ALEMBIC PHARMA, and the dividend history of PLETHICO PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.